PGPhilimon Nyakauru Gona

Philimon Nyakauru Gona

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Philimon Nyakauru Gona has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Associations of Angiotensin‐Converting Enzyme 2 Activity With Markers of Endothelial Dysfunction and Oxidative Stress in Young Healthy Adults: The African‐PREDICT Study

    by Vuledzani Felicia Maugana, Louise M. Burrell, Sheila K. Patel, Catharina Martha C. Mels, Aletta Elisabeth Schutte, Maserame Cleopatra Mokhaneli, Nonkululeko Hellen Navise, Thabisile Mpofana, Philimon N. Gona, Lebo Francina Gafane‐Matemane

    Background: Activation of the renin–angiotensin–aldosterone‐system plays a major role in the pathogenesis of cardiovascular disease through, among others, endothelial dysfunction and oxidative stress. Circulating ACE2 (angiotensin‐converting enzyme 2) is emerging as a biomarker of cardiovascular disease risk; however, its role in younger populations is not well‐established. This study aimed to investigate sex differences in serum ACE2 activity and associations with endothelial dysfunction and oxidative stress‐related markers in young, apparently healthy men and women. Methods: In this cross‐sectional study, we included 1134 young (aged 20–30 years) men (n=557) and women (n=577). Serum ACE2 activity was measured using a validated fluorometric assay. We analyzed markers of endothelial dysfunction, oxidative stress, and antioxidant capacity. We performed a 2‐sample t test and Mann‐Whitney U test. We applied multivariable‐adjusted Tobit regression analysis to account for left truncation. Results: Men had higher ACE2 activity than women ( P P =0.006), and a disintegrin‐like metalloproteinase with thrombospondin motif type 1 member 13 ( P =0.019) in men. Among women, ACE2 activity was negatively associated with asymmetric dimethylarginine ( P =0.043) and superoxide dismutase ( P =0.004). Conclusions: Serum ACE2 activity was higher in men than women and showed sex‐specific associations with endothelial dysfunction and oxidative stress‐related markers. Our results suggest an association between ACE2 shedding and pathophysiological processes associated with alterations in endothelial integrity and early endothelial dysfunction, which may be influenced by sex. This highlights the role of circulating ACE2 as a potential early biomarker of cardiovascular disease risk in young adults. Registration: URL: https://clinicaltrials.gov ; Unique identifier: NCT03292094.

  • Open Access

    Correction: Racial disparity in mortality from tuberculosis in the US between states with and without a history of Jim‑Crow laws: an analysis of the Global Burden of Disease (GBD) and risk factors study, 1990 to 2019

    by Philimon N. Gona, Lorena M. Estrada‑Martinez, Lingling Zhang, Clara M. Gona, Aaloke Mody, Sowmya R. Rao, Joseph Cooper, Kibibi Mack‑Shelton, Ping Chen, Suzanne G. Leveille, et al.

  • Open Access

    Clinical Evaluation of a Markerless Motion Capture Technology: Reliability and Usability for Musculoskeletal Assessment

    by University of South Dakota, Meghan E. Garvey, Jeremy D. Hernandez, Leidos QTC Health Services, Philimon Nyakauru Gona, University of Massachusetts Boston, Brant Hannahs, Daniel E. Highland, Donald J. Kosiak Jr., University of South Dakota Sanford School of Medicine

    BACKGROUND While various technologies have recently emerged as prominent tools in healthcare, particularly for augmenting screening and diagnostic processes, evaluations of their accuracy and reliability within clinical musculoskeletal (MSK) settings remain limited. METHODS This was a cross-sectional clinical evaluation and usability study of a markerless motion capture system (MMCS) compared with the standard of care using a manual goniometer in a healthy adult population. Ten range of motion (ROM) measurements (degrees) were taken on the same participant using both methods. Active, passive, and 3-repeat active joint ROM measurements were taken for the right and left sides. Mean paired differences between left and right pairs of MMCS and standard of care measurements were calculated and statistically compared using a paired t-test. Quintiles for each pair of ROM measurements were determined. Agreement of pair of ROM measurements was assessed using the cross-tabulations of the quintiles. Cohen’s kappa statistic, a measure of inter-rater reliability (comparing categories of manual goniometer vs. MMCS) was calculated. Intra-class correlation coefficient (ICC) was used to assess the reliability of each joint pair of ROMs. Mean absolute differences in ROM between joint pairs were calculated. A two-sided p-value RESULTS For active, passive, and 3-repeat active range of motion (ROM) showed fair agreement between manual goniometer and MMC measurements for active ROM, with kappa statistics ranging from 0.32 to 0.37. The ICCs varied across joints, ranging from .121 (active ROM left thoracolumbar rotation) to .960 (3-Repeat active ROM left shoulder internal rotation). Paired t-test of ROMs revealed statistically significant differences between the two methods for all joints except for active knee extension. About 40% of the mean absolute differences between ROM pairs were within ±5 degrees. CONCLUSION Mean differences between pairs of ROM measurements for manual goniometer vs. MMCS varied widely. Inter-rater reliability showed poor to excellent agreement. Reliability assessed using the ICC ranged from weak to strong. Future studies evaluating MMCS for screening purposes rather than diagnostic-level accuracy are needed. The reliability of the MMCS algorithm needs improvement before the technology can be scaled up.

  • Open Access

    Racial disparity in mortality from tuberculosis in the US between states with and without a history of Jim-Crow laws: an analysis of the Global Burden of Disease (GBD) and risk factors study, 1990 to 2019

    by Philimon N. Gona, Lorena M. Estrada-Martinez, Lingling Zhang, Clara M. Gona, Aaloke Mody, Sowmya R. Rao, Joseph Cooper, Kibibi Mack-Shelton, Ping Chen, Suzanne G. Leveille, et al.

    While TB-related mortality in the US declined four-fold from 1990 to 2019, country-level estimates of TB burden obscure within-state racial heterogeneity and changes in TB burden over time. In sixteen US Southern States and Washington DC, the effects of health inequities engendered by Jim-Crow laws enacted from the late 1800s to the 1960s have not been evaluated for TB-related mortality. We, therefore, sought to compare TB mortality rates and annualized rate of change (AROC) between 1990 and 2019 in former Jim-Crow vs. non-Jim-Crow states to help guide response efforts and inform resource prioritization to improve racial equity. We evaluated whether TB-related mortality varied over time, from 1990 to 2019, between states that have a history of enacting Jim-Crow laws vs. states with no such history using estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019). TB mortality per 100,000 population and bootstrap 95% uncertainty intervals (UIs) were modeled using the Cause of Death Ensemble model (CODEm) framework with varying combinations of predictive covariates. For changes over time, we present age-standardized AROC as the percent difference in the natural logarithm of the rate in 1990 and 2019 divided by 30 (i.e., 100*[ln(2019 Rate/1990 Rate)/(30)) and the corresponding 95% UIs. TB-related mortality in all US states declined between 1990 and 2019. From 1990 to 2019, most former Jim-Crow states had higher mortality rates than states that did not enact Jim-Crow laws. The most significant decline in TB mortality was in Washington DC, with a six-fold decline from 2.69 (2.46–2.96) per 100,000 population in 1990 to 0.45(0.37–0.55) in 2019, corresponding to an AROC of -0.83% (-0.86;-0.79). The lowest decline was in Iowa, from 0.30 (0.27–0.33) to 0.09 (0.07–0.11) (AROC: -0.70% (-0.76; -0.63)). Eleven of the 16 states and Washington DC in the third tertile of TB mortality rate in 1990 (range 0.81–2.69) had a history of Jim-Crow laws, whereas none of the 17 states in the first tertile (range 0.30–0.51) had such history. Conversely, mortality decreased relatively slowly in former Jim-Crow states than in non-Jim-Crow states. Even though the 1964 Civil Rights Act dismantled Jim-Crow statutes, racial inequities in TB burden experienced by past generations may still be felt in subsequent generations. Understanding the role of structural racism at the intersection of science and medicine shows the complex ways historical laws, such as Jim-Crow laws, continue to negatively impact health outcomes and warn of future dangers, such as COVID-19, to avoid.


  • Open Access

    Trends in the burden of most common obesity‐related cancers in 16 Southern Africa development community countries, 1990–2019. Findings from the global burden of disease study

    by Philimon Gona, Clara Gona, Suha Ballout, Chabila Mapoma, Sowmya Rao, Ali Mokdad

    Background: Obesity‐related cancers in the 16 Southern African Development Community (SADC) countries is quite prominent. The changes and time trends of the burden of obesity‐related cancers in developing countries like SADC remain largely unknown. A descriptive epidemiological analysis was conducted to assess the burden of obesity‐related cancers, (liver, esophageal, breast, prostate, colon/rectal, leukemia, ovarian, uterine, pancreatic, kidney, gallbladder/biliary tract, and thyroid cancers) in SADC countries.Methods: Data from the 2019 Global Burden of Diseases Study was used. Deaths extracted from vital registration, verbal autopsies and ICD codes. Cancer‐type, mortality and prevalence per 100,000 population and 95% uncertainty intervals (UIs) were calculated using the Cause of Death Ensemble model and Spatio‐Temporal Gaussian process with mixed effects regression models. Annual rates of change (AROCs) between 1990 and 2019 and the corresponding UIs were calculated.Results: The top age‐standardized mortality rates per 100,000 in 2019 for males were leukemia, 20.1(14.4–26.4), esophageal cancer, 15.1 (11.2–19.1), and colon and rectal cancer, 10.3 (8.6–12.6). For females, breast cancer, 20.6 (16.6–25.0), leukemia, 17.1 (11.4–23.7), and esophageal cancer, 8.3 (5.5–10.7), had the leading mortality rates. For males, AROC substantial (p < 0.05) increase for kidney cancer for 11 of the countries (AROC from 0.41% to 1.24%), colon cancer for eight of the countries (from 0.39% to 0.92%), and pancreatic cancer for seven countries (from 0.26% to 1.01%). In females, AROC showed substantial increase for pancreatic cancer for 13 of the countries from (0.34%–1.67%), nine countries for kidney cancer (from 0.27% to 1.02%), seven countries each for breast cancer (0.35%–1.13%), and ovarian cancer (from 0.33% to 1.21%).Conclusions: There is need for location‐specific and culturally appropriate strategies for better nutrition and weight control, and improved screening for all cancers. Health promotion messaging should target kidney, colon, pancreatic, and breast cancers and encourage clinically tested methods of reducing BMI such as increasing personal physical activity and adoption of effective dietary regimes.


  • Association of Parental Cardiovascular Health With Disability-Adjusted Life Years in the Offspring: Results From the Framingham Heart Study

    by James M. Muchira, Philimon N. Gona, Mulubrhan F. Mogos, Eileen M. Stuart-Shor, Suzanne G. Leveille, Mariann R. Piano, Laura L. Hayman

    Background: Disability-adjusted life years (DALYs) are used to evaluate the relative burden of diseases in populations to help set prevention or treatment priorities. The impact of parental cardiovascular health (CVH) on healthy life years lost from cardiovascular disease (CVD) in adult offspring is unknown. We compared parent-offspring CVD DALYs trends over the life course and examined the association of parental CVH with offspring CVD DALYs. Methods: Using data from the Framingham Heart Study, 4814 offspring-mother-father trios were matched for age at selected baseline exams. CVH score was computed from the number of CVH metrics attained at recommended levels: poor (0–2), intermediate (3–4), and ideal (5–7). CVD DALYs were defined as the sum of years of life lost and years lived with CVD. Age-sex-standardized life expectancy and disability weights were derived from the actuarial life tables and Global Burden of Disease study, respectively. Multivariable-adjusted linear regression was used to investigate the association of parental CVH with offspring CVD DALYs. Results: Over an equal 47-year follow-up, parents lost nearly twice the number of CVD DALYs compared to their offspring (23 234 versus 12 217). However, age-adjusted CVD DALYs were higher at younger ages and similar along the life course for parents and offspring. One-unit increase in parental CVH was associated with 5 healthy life months saved in offspring. Offspring of mothers with ideal versus poor CVH had 3 healthy life years saved (β=−3.0 DALYs [95% CI, −5.6 to −0.3]). No statistically significant association was found between paternal CVH categories and offspring CVD DALYs. Conclusions: Higher maternal and paternal CVH were associated with increased healthy life years in offspring; however, the association was strongest between mothers and offspring. Investment in CVH promotion along the life course has the potential to reduce the burden of CVD in the current and future generation of adults.


  • Bacterial pathogens and climate change

    by Philimon N Gona, Alexander F More


  • Relation of MRI Aortic Wall Area and Plaque to Incident Cardiovascular Events: The Framingham Heart Study

    by Ulf Neisius, Philimon N. Gona, Noriko Oyama-Manabe, Michael L. Chuang, Christopher J. O’dOnnell, Warren J. Manning, Connie W. Tsao

    In middle-aged community-dwelling adults without prevalent cardiovascular disease (CVD), aortic arteriosclerosis and atherosclerosis at MRI were associated with incident CVD events. Background Arterial arteriosclerosis and atherosclerosis reflect vascular disease, the subclinical detection of which allows opportunity for cardiovascular disease (CVD) prevention. Larger cohort s...


  • Open Access

    Soluble (Pro)renin Receptor Is Adversely Associated with Indices of Left Ventricular Structure and Function: The African-PREDICT Study

    by Lebo F. Gafane-Matemane, Ruan Kruger, Johannes M. Van Rooyen, Philimon N. Gona, Aletta E. Schutte

    This study aims to compare soluble (pro)renin receptor [s(P)RR] levels between black and white adults and to explore the associations of left ventricular (LV) structure and function with s(P)RR in the total and ethnicity-stratified groups. The study sample included 1172 apparently healthy black (n = 587) and white (n = 585) participants of the African-PREDICT study aged 20–30 years. Echocardiography was performed to determine relative wall thickness (RWT), LV mass index, LV ejection fraction and stroke volume index (SVi). s(P)RR was analyzed from serum samples, while plasma renin activity-surrogate (PRA-S) and eq angiotensin II were determined using the RAS™ Fingerprint. s(P)RR was higher in the white participants compared to the black participants (p < 0.001). In multivariable-adjusted linear regression analyses, we observed a positive association between RWT and s(P)RR (β = 0.141; p = 0.005) and negative associations of LV ejection fraction (β = −0.123; p = 0.016) and SVi (β = −0.144; p = 0.004) with s(P)RR only in white adults. Higher s(P)RR observed in white vs. black participants was associated with higher RWT and poorer LV function only in young white adults but not in their black counterparts. These results suggest that s(P)RR may contribute to LV remodeling and dysfunction in white populations due to its role in volume–pressure regulation and its proinflammatory as well as profibrotic effects.


  • African Immigrant Health: The Health Promotion Beliefs of Zimbabwean Immigrants in the United States

    by Clara M. Gona, Ruth Palan-Lopez, Lisa Wood, Rosalia S. Gotora, Philimon N. Gona

    To examine the health beliefs that can influence engagement in cardiovascular disease (CVD) risk reduction health promotion activities among Zimbabwe-born immigrants in the US. Focus group interviews with 37 New England-based Zimbabwean immigrants in the US conducted between January and April 2019. Focus groups were led by study investigators who were members of the Zimbabwean community. Interviews were audio-recorded and transcribed. Data were analyzed using framework analysis. Five themes emerged: (1) negative attitudes toward ill health, (2) mistrust toward western medicine, (3) stigma and taboo toward ill health, (4) a negative change in eating habits and (5) negative attitudes toward physical exercise. The participants’ attitudes and beliefs may interfere with their engagement in health promotion activities aimed at reducing the burden of CVD risk in this population. Understanding these beliefs paves the way for development of culturally congruent health promotion interventions in Zimbabwean and other African immigrant populations.